Example: Heart Attack

Search clinical trials for: Contraceptives, Postcoital

Total 178 results

NCT04458558

Recruiting

Improving Access to Abortion in the Republic of Georgia

Conditions: Abortion Early; Pregnancy Related
NCT04254627

Recruiting

Tumor Necrosis Factor (TNF) and Glucocorticoid Antagonist for Gulf War Illness (GWI)-Associated Multi-symptom Disease Homeostasis Reset

Conditions: Gulf War Illness
NCT04255498

Recruiting

Understanding GWI: Integrative Modeling

Conditions: Gulf War Illness; Persian Gulf Syndrome; Occupational Diseases
NCT04131517

Terminated

A Study to Test the Interaction of Padsevonil With Oral Contraceptives in Healthy Female Participants

Conditions: Healthy Female Participants
NCT04063904

Not yet recruiting

Pilot Study of an Ambulatory Medical Abortion Service at 13-18 Weeks of Gestation in Colombia

Conditions: Second Trimester Abortion
NCT03972358

Recruiting

Assessing Medical Menstrual Regulation in the United States

Conditions: Menstrual Regulation
NCT03913104

Recruiting

Mail Order Mifepristone Study

Conditions: Abortion Early; Pregnancy Related
NCT03829696

Withdrawn

Advance Provision of Medication Abortion

Conditions: Early Abortion
NCT03774745

Terminated

Blocking Mifepristone Action With Progesterone

Conditions: Pregnancy, Unwanted
NCT03745144

Active, not recruiting

Effects of Cladribine Tablets on the Pharmacokinetics of Microgynon®

Conditions: Relapsing Multiple Sclerosis (RMS)
NCT03714880

Recruiting

Cervical Preparation With Mifepristone Prior to Osmotic Dilators

Conditions: Second Trimester Abortion
NCT03675581

Completed

A Study to Test Whether Nintedanib Influences the Components of Birth-control Pills in Women With Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)

Conditions: Scleroderma, Systemic
NCT03520439

Completed

Evaluation of Therapeutic Effect and Safety of Mifepristone in the Treatment of Adenomyosis

Conditions: Adenomyosis
NCT03508635

Completed

CORT125134 Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD)

Conditions: Healthy
NCT03346629

Completed

Outpatient Service for Mid-trimester Termination of Pregnancy

Conditions: Abortion in Second Trimester
NCT03320057

Recruiting

Medication Abortion Via Pharmacy Dispensing

Conditions: Pregnancy Related; Abortion Early
NCT03269279

Recruiting

Mifepristone and Misoprostol for 2nd Trimester Termination of Pregnancy in Burkina Faso

Conditions: Medical; Abortion, Fetus
NCT03258372

Completed

Crossover Drug-Drug Interaction Study to Determine Effects of Cytochrome P450 3A on Exposure to Mifepristone and Its Metabolites

Conditions: Healthy
NCT03259542

Completed

Mifepristone Drug-Drug Interaction Study With CYP3A Inhibitor

Conditions: Drug Interaction Potentiation; Healthy
NCT03248713

Terminated

Glucocorticoid Antagonist Treatment for Tobacco Use Disorder

Conditions: Nicotine Dependence
NCT03225547

Active, not recruiting

Study of Pembrolizumab and Mifepristone in Patients With Advanced HER2-negative Breast Cancer

Conditions: Advanced HER2-negative Breast Cancer
NCT03212352

Terminated

Comparing Two Medical Treatments for Early Pregnancy Failure.

Conditions: Early Pregnancy Failure
NCT03210246

Completed

Drug-drug Interaction Study: Influence of Vilaprisan on Pharmacodynamics (PD) and Pharmacokinetics (PK) of a Combined Oral Contraceptive (COC)

Conditions: Clinical Trial ,Phase I
NCT03210324

Terminated

A Study on the Mifepristone Tablets in the Treatment of Symptomatic Uterine Fibroids With Safety and Efficacy

Conditions: Uterine Fibroid
NCT03194126

Recruiting

Evaluation of Efficacy of Two Therapeutic Strategies for Cervical Maturation Before Medical Termination

Conditions: Medical; Abortion, Fetus
NCT03193307

Completed

This Study Tests in Healthy Korean Women Which Effects BI 409306 and a Birth-control Pill Have on Each Other

Conditions: Healthy
NCT03065660

Completed

Mifepristone and Misoprostol Versus Misoprostol Alone in the Medical Management of Missed Miscarriage

Conditions: Missed Miscarriage
NCT03052400

Recruiting

Efficacy of Mifepristone in Males With Type 2 Diabetes Mellitus

Conditions: Type 2 Diabetes Mellitus; Insulin Resistance
NCT03044093

Unknown status

Mifepristone and Misoprostol Compared With Misoprostol Alone for Second Trimester Abortion

Conditions: Second Trimester Abortion
NCT03043014

Completed

Cervical Preparation of Abortions Under Paracervical Block in the First Trimester:

Conditions: Surgical Abortion
NCT03015701

Completed

S9005 Mifepristone in Meningioma

Conditions: Meningioma
NCT02989662

Recruiting

INIA Stress and Chronic Alcohol Interactions: Glucocorticoid Antagonists in Heavy Drinkers

Conditions: Alcohol Use Disorder
NCT02985229

Completed

Acceptability and Feasibility of Medical Abortion in Singapore

Conditions: Medical Abortion
NCT02981030

Completed

Acceptability and Feasibility of a Simplified Medical Abortion Service Delivery in Western Ukraine

Conditions: Abortion, Therapeutic
NCT02845219

Completed

A Trial Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Ethinylestradiol and Levonorgestrel in an Oral Contraceptive Combination Drug in Healthy Postmenopausal Females

Conditions: Diabetes; Diabetes Mellitus, Type 2
NCT02788981

Recruiting

Abraxane® With or Without Mifepristone for Advanced, Glucocorticoid Receptor-Positive, Triple-Negative Breast Cancer

Conditions: Breast Cancer
NCT02751385

Terminated

Investigation of the Effect of Nintedanib on the Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Patients With Non-small Cell Lung Cancer

Conditions: Carcinoma, Non-Small-Cell Lung
NCT02745093

Unknown status

Medical Abortion at Gestational Age of 8 to ≤9 Weeks Versus >9 to ≤12 Weeks

Conditions: Medical Abortion
NCT02720991

Completed

A Pilot of an Outpatient Regimen of Medical Abortion With Mifepristone and Sublingual Misoprostol in the 11 and 12 Weeks

Conditions: Abortion, 3 Months
NCT02708446

Unknown status

A Comparison of Sublingual and Buccal Misoprostol Regimens After Mifepristone for Mid-trimester Abortion

Conditions: Legally Induced Abortion Without Mention of Complication
NCT02704481

Suspended

Non-surgical Alternatives to Treatment of Failed Medical Abortion

Conditions: Abortion Failure
NCT02697851

Terminated

Pharmacokinetic Effect of Evotaz/Microgynon Co-administration

Conditions: HIV
NCT02689804

Completed

EC PK in Women With Normal and Obese BMI

Conditions: Contraception
NCT02679092

Withdrawn

Mifepristone Versus Osmotic Dilators in Conjunction With Misoprostol for Cervical Preparation Prior to D&E at 14-19 Weeks

Conditions: Legally Induced Abortion Without Mention of Complication
NCT02651844

Active, not recruiting

Mifepristone for Breast Cancer Patients With Higher Levels of Progesterone Receptor Isoform A Than Isoform B.

Conditions: Breast Cancer
NCT02642939

Recruiting

Study of Oral Mifepristone as Salvage Therapy in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer

Conditions: Non-Small Cell Lung Cancer (NSCLC)
NCT02633761

Terminated

Mifepristone-misoprostol vs. Misoprostol Alone for Second Trimester Fetal Death

Conditions: Fetal Death
NCT02620904

Active, not recruiting

Mifepristone Induction for Fetal Demise

Conditions: Intrauterine Fetal Demise; Fetal Death
NCT02412618

Completed

Same-Day Mifepristone-Misoprostol Compared to Misoprostol Only for Surgical Abortion Cervical Preparation

Conditions: Induced Abortion
NCT02404038

Active, not recruiting

A Study to Evaluate the Acceptability and Preference for Contraceptive Options as Proxy for HIV Prevention Methods

Conditions: HIV